Cytokinetics Inc (CYTK)
48.51
-0.61
(-1.24%)
USD |
NASDAQ |
May 31, 16:00
48.55
+0.04
(+0.08%)
After-Hours: 20:00
Cytokinetics Research and Development Expense (TTM)
Research and Development Expense (TTM) Chart
Historical Research and Development Expense (TTM) Data
| Date | Value |
|---|---|
| September 30, 2010 | 38.67M |
| June 30, 2010 | 38.98M |
| March 31, 2010 | 38.95M |
| December 31, 2009 | 39.84M |
| September 30, 2009 | 41.49M |
| June 30, 2009 | 45.15M |
| March 31, 2009 | 49.81M |
| December 31, 2008 | 53.95M |
| September 30, 2008 | 56.44M |
| June 30, 2008 | 56.14M |
| March 31, 2008 | 55.00M |
| December 31, 2007 | 53.39M |
| Date | Value |
|---|---|
| September 30, 2007 | 52.46M |
| June 30, 2007 | 51.77M |
| March 31, 2007 | 50.44M |
| December 31, 2006 | 49.22M |
| September 30, 2006 | 46.93M |
| June 30, 2006 | 43.66M |
| March 31, 2006 | 41.30M |
| December 31, 2005 | 40.57M |
| September 30, 2005 | 41.05M |
| June 30, 2005 | 41.32M |
| March 31, 2005 | 41.06M |
| December 31, 2004 | 39.88M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| Amgen Inc | 5.069B |
| Viking Therapeutics Inc | 76.90M |
| Johnson & Johnson | 15.30B |
| Eli Lilly and Co | 9.851B |
| Madrigal Pharmaceuticals Inc | 281.43M |